Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV

Antiviral Chemistry and Chemotherapy

Volumn 14, Issue 5, 2003, Pages 271-279

  Maruyama, Tokumi ^a,b   Kozai, Shigetada ^a   Yamasaki, Tetsuo ^b   Witvrouw, Myriam ^c   Pannecouque, Christophe ^c   Balzarini, Jan ^c   Snoeck, Robert ^c   Andrei, Graciella ^c   De Clercq, Erik ^c  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

1,3 disubstituted uracil; HCMV; HIV; NNRTI

Indexed keywords

1 BENZYL 3 (3,5 DIMETHYLBENZYL)URACIL; 1 CYANOMETHYL 3 (3,5 DIMETHYLBENZYL) 4 THIOURACIL; 1 CYANOMETHYL 3 (3,5 DIMETHYLBENZYL)URACIL; ANTIVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0344236355     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020301400506     Document Type: Article

References (25)

1. Baba M, Tanaka H, De Clercq E, Pauwels R, Balzarini J, Schols D, Nakashima H, Perno C-F, Walker RT & Miyasaka T (1989) Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. Biochemical & Biophysical Research Communications 165: 1375-1381.
2. Baba M, De Clercq E, Tanaka H, Ubasawa M, Takashima H, Sekiya K, Nitta I, Umezu K, Nakashima H, Mori S, Shigeta S, Walker RT & Miyasaka T (1991) Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proceedings of the National Academy of Sciences, USA 88:2356-2360.
3. Baker BR & Kawazu M (1967) Irreversible enzyme inhibitors. LXXVI. Journal of Medicinal Chemistry 10:302-304.
4. Buckheit RW Jr, Watson K, Fliakas-Boltz V, Russell J, Loftus TL, Osterling MC, Turpin JA, Pallansch LA, White EL, Lee JW, Lee SH, Oh JW, Kwon HS, Chung SG & Cho EH (2001) SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2. Antimicrobial Agents & Chemotherapy 45: 393-400.
5. Clivio P, Fourrey J-L, Gasche J & Favre A (1992) Synthesis of deoxydinucleoside phosphates containing 4-thio substituted pyrimidine nucleobases. Journal of the Chemical Society (Prekin Transactions) 1: 2383-2388.
6. 3-methyl-4-thiothymidine. Journal of Organic Chemistry 59: 7273-7283.
7. De Clercq E (1995) Antiviral therapy for Human Immunodeficiency virus infections. Clinical Microbiology Reviews 8: 200-239.
8. De Clercq E (1996) Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development. Medicinal Research Reviews 16:125-157.
9. De Clercq E (1996) What can be expected from non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the treatment of human immunodeficiency virus type 1 (HIV-1) infections? Reviews in Medical Virology 6:97-117.
10. Fox JJ, Praag DV, Wempen I, Doerr IL, Cheong L, Knoll JE, Eidinoff ML, Bendich A & Brown GB (1959) Thiation of nucleosides. II. Synthesis of 5-methyl-2′-deoxycytidine and related pyrimidine nucleosides. Journal of the American Chemical Society 81:178.
11. Grangier G, Aitken DJ, Guillaume D, Tomas A, Viossat B & Husson H-P (1994) Reactivity of nucleophilic uracil derivatives. Journal of Heterocyclic Chemistry 31: 1707-1714.
12. Hilbert GE & Johnson TB (1930) Reserches on pyrimidines. CXV. Alkylation on nitrogen of the pyrimidine cycle by application of a new technique involving molecular rearrangements. Journal of the American Chemical Society 52:2001-2007.
13. Ishikawa I, Itoh T, Takayanagi H, Oshima J, Kawahara N, Mizuno Y & Ogura H (1991) The photocycloaddition reactions of uridine and related compounds with 2,3-dimethyl-2-butene. Chemical & Pharmaceutical Bulletin 39: 1922-1930.
14. Kozai S, Fukagawa T & Maruyama T (1998) A new method for the synthesis of N3-alkylated analogs of 5-fluorouracil. Journal of the Chemical Society Prekin Transactions 1:3145-3146.
15. Lazrek HB, Taourirte M, Oulih T, Kabbaj Y, Barascut JL, Imbach JL, Almasoudi N & Pfleiderer W (1997) Synthesis of 3′-deoxy-3′ and 5′-deoxy-5-[4-purin-9-yl/pyrimidin-1-yl)methyl-1,2,3-triazol-1-yl] thymidine via 1,3-dipolar cycloaddition. Nucleosides & Nucleotides 16: 1073-1077.
16. Mai A, Artico M, Sbardella G, Massa S, Novellino E, Greco G, Loi AG, Tramontano E, Marongiu ME & La Colla P (1999) 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenyl-methyl)-3,4-dihydropyrimidin-4(3H) -ones: Novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives. Journal of Medicinal Chemistry 42: 619.
17. Maruyama T, Kozai S & Uchida M (1999) Synthesis of N-aryl uracils and hypoxanthines and their biological properties. Nucleosides & Nucleotides 18: 661-671.
18. Maruyama T, Fujiwara K & Fukuhara M (1995) A new method for the synthesis of N-phenyl uracil and pyrimidine nucleosides. Journal of the Chemical Society (Prekin Transactions) 1:733-734.
19. Mitsunobu O (1981) The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1-28.
20. Noell CW & Cheng CC (1978) 1-(Tetrahydro-2-furyl)pyrimidines. Nucleic Acid Chemistry. Edited by RS Tipson & LB Townsend. New York, John Wiley & Sons, pp 57-66.
21. Nugent RA, Schlachter ST, Murphy MJ, Cleek GJ, Poel TJ, Wishka DG, Graber DR, Yagi Y, Keiser BJ, Olmsted RA, Kopta LA, Swaney SM, Poppe SM, Morris J, Tarpley WG & Thomas RC (1998) Pyrimidine thioethers: A novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIV. Journal of Medicinal Chemistry 41: 3793-3803.
22. Pedersen OS & Pedersen EB (2000) The floursishing syntheses of non-nucleoside reverse transcriptase inhibitors. Synthesis 479-495.
23. Singh H, Aggarwal P & Kumar S (1980) A facile synthesis of 1-monosubstituted and unsymmetrically 1,3-disubstituted uracils. Synthesis 520.
24. Syper L, Skrowaczewska Z & Bytnar A (1967) Rearrangements of 2,4,6-collidine N-oxide under the action of acetic anhydride. Roczniki Chemii 41:1027-1035.
25. Szczech GM, Furman P, Painter GR, Barry DW, Borroto-esoda K, Grizzle TB, Blum MR, Sommadossi J-P, Endoh R, Niwa T, Yamamoto M & Moxham C (2000) Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. AntimicrobialAgents & Chemotherapy 44: 123-130.